We identified a list of 48 sgRNAs showing enrichment or depletion specifically in the anti–PD-1–treated condition (table S1), suggesting that perturbation of the corresponding genes may regulate tumor cells fitness under anti–PD-1–selective pressure. This evidence concerns the gene PDCD1 and neoplasm.